. 2022 Dec 5;10:e14481. doi: 10.7717/peerj.14481

Table 2. Univariate and multivariate analysis of factors that contribute to clinical remission in IgA nephropathy.

Variable	Univariate Analysis			Multivariate Analysis
	HR	95% CI	P-value	HR	95% CI	P-value
Age (per decade)	1.02	(0.84–1.22)	0.872	1.11	(0.90–1.37)	0.337
Gender (male vs female)	0.80	(0.59–1.09)	0.158	0.71	(0.48–1.05)	0.088
Hematuria (vs no hematuria)	0.53	(0.36–0.80)	0.003^*	0.59	(0.38–0.90)	0.015^*
Proteinuria (g/24h)	0.71	(0.57–0.89)	0.003^*	0.74	(0.57–0.95)	0.017^*
Serum creatinine (per 10 µmoI/L)	0.96	(0.91–1.02)	0.145	0.98	(0.89–1.07)	0.585
Mean arterial pressure (per 10 mmHg)	0.98	(0.86–1.11)	0.743	1.06	(0.92–1.23)	0.426
M (M0 vs M1)	0.78	(0.58–1.06)	0.112	0.74	(0.54–1.03)	0.073
E (E0 vs E1)	0.47	(0.07–3.33)	0.446	0.60	(0.08–4.73)	0.630
S (S0 vs S1)	1.32	(0.90–1.94)	0.152	1.51	(0.99–2.28)	0.053
T (T0 vs T1+T2)	0.49	(0.32–0.75)	0.001^*	0.50	(0.31–0.81)	0.005^*
C (C0 vs C1+C2)	1.04	(0.75–1.45)	0.797	1.27	(0.89–1.83)	0.188
Tonsillectomy	1.75	(1.28–2.39)	<0.001^*	1.77	(1.29–2.42)	<0.001^*
Steroid/Immunosuppressant	0.91	(0.67–1.24)	0.550	1.00	(0.72–1.39)	0.990
RAS inhibitor	0.99	(0.71–1.40)	0.965	0.99	(0.68–1.44)	0.974

Notes.

Statistically significant.